Kyrgyzstan was NewGenIvf’s largest region in fiscal 2025, bringing in $9.25M of $18.91M (49%).
| Geography | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Kyrgyzstan | $20.24M | $12.49M | $10.63M | $9.25M | |
| Thailand | $2.02M | $5.43M | $8.70M | $6.77M | |
| Cambodia | $1.51M | $2.49M | $2.41M | $2.54M | |
| Us | — | — | — | $181.92K | |
| China / Hk Sar | — | — | — | $166.22K | |
| Hk Sar | — | $136.15K | — | — | |
| Total | $23.78M | $20.54M | $21.73M | $18.91M |
NewGenIvf brought in $18.91M from its five regions in fiscal 2025, the year ended December 31, 2025. NewGenIvf regrouped these regions after fiscal 2024, so the total does not compare directly with that year's $21.73M. Kyrgyzstan was the largest at $9.25M (48.9%), ahead of Thailand at $6.77M (35.8%) and Cambodia at $2.54M (13.4%). The other two regions brought in $348.14K combined.
Compared with fiscal 2024, Cambodia grew fastest, up 5.6% to $2.54M, while Thailand fell the most, down 22.2% to $6.77M.
NewGenIvf began breaking out Us in fiscal 2025 and China / Hk Sar in fiscal 2025. NewGenIvf stopped reporting Hk Sar as a separate region after fiscal 2023, when it brought in $136.15K.
Ivf Treatment Service was NewGenIvf’s largest product and service line in fiscal 2025, bringing in $15.62M of $18.91M (83%).
| Product and Service | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Ivf Treatment Service | $11.28M | $16.09M | $21.73M | $15.62M | |
| Surrogacy, Ancillary Caring & Other Services | $12.50M | $4.46M | — | — | |
| Fertility Referral Services | — | — | — | $3.28M | |
| Total | $23.78M | $20.54M | $21.73M | $18.91M |
NewGenIvf brought in $18.91M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. NewGenIvf regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $21.73M. Ivf Treatment Service was the largest at $15.62M (82.6%), ahead of Fertility Referral Services at $3.28M (17.4%).
NewGenIvf began breaking out Fertility Referral Services in fiscal 2025, when it brought in $3.28M. NewGenIvf stopped reporting Surrogacy, Ancillary Caring & Other Services as a separate line after fiscal 2023, when it brought in $4.46M.
NewGenIvf (NIVF) reports its revenue by geography and by product and service. In fiscal 2025, Kyrgyzstan was its largest region, bringing in $9.25M (48.9% of the total), followed by Thailand at $6.77M (35.8%).
Kyrgyzstan was NewGenIvf's largest region in fiscal 2025, bringing in $9.25M, or 48.9% of the $18.91M total across its five regions.
Ivf Treatment Service was NewGenIvf's largest product and service line in fiscal 2025, bringing in $15.62M, or 82.6% of the $18.91M total across its two product and service lines.
Every figure comes from NewGenIvf's annual financial filings, as reported. Each line keeps the name NewGenIvf gives it, and years follow its fiscal calendar.
NewGenIvf's revenue by geography goes back to fiscal 2021, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.